The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Open accessAbstract
Cytotoxic T lymphocytes and NK cells play an important role in eliminating malignant tumor cells and the number and activity of tumor-infiltrating T cells represent a good marker for tumor prognosis. Based on these findings, immunotherapy, e.g., checkpoint blockade, has received considerable attention during the last couple of years. However, for the majority of patients, immune control of their tumors is gray theory as malignant cells use effective mechanisms to outsmart the immune system. Increasing evidence suggests that changes in tumor metabolism not only ensure an effective energy supply and generation of building blocks for tumor growth but also contribute to inhibition of the antitumor response. Immunosuppression in the tumor microenvironment is often based on the mutual metabolic requirements of immune cells and tumor cells. Cytotoxic T and NK cell activation leads to an increased demand for glucose and amino acids, a well-known feature shown by tumor cells. These close metabolic interdependencies result in metabolic competition, limiting the proliferation, and effector functions of tumor-specific immune cells. Moreover, not only nutrient restriction but also tumor-driven shifts in metabolite abundance and accumulation of metabolic waste products (e.g., lactate) lead to local immunosuppression, thereby facilitating tumor progression and metastasis. In this review, we describe the metabolic interplay between immune cells and tumor cells and discuss tumor cell metabolism as a target structure for cancer therapy. Metabolic (re)education of tumor cells is not only an approach to kill tumor cells directly but could overcome metabolic immunosuppression in the tumor microenvironment and thereby facilitate immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 1×
“Lactic acid also induces M2-polarization in TAMs via HIF-1α stabilization (96).”
BackgroundUyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305 · cited 2×
“Regarding availability of tryptophan, IDO is overexpressed in many cancers and IDO-expressing tumor cells are not rejected by specific T cells (30).”
BackgroundPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · cited 2×
“Glutamine is essential for proliferation (38, 77, 78) during the initial growth phase as well as for protein and lipid biosynthesis in T cells (38) and for inflammasome activity, phagocytosis, and antigen expression in myeloid cells (79, 80).”
BackgroundMichalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091
Jha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
Self-citationInhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Self-citationL-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Self-citationImmunometabolism governs dendritic cell and macrophage function
O’Neill, L. A. J., & Pearce, E. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151570 · Cited by 1,694
Tlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 1×
“Inhibition of T cell mTORC1 via rapamycin results in inhibition of glycolysis (46) and enhances CD8 memory generation (52, 53).”
BackgroundInhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Buck, M. D., O’Sullivan, D., Klein Geltink, R. I., Curtis, J. D., Chang, C.-H., Sanin, D. E., Qiu, J., Kretz, O., Braas, D., van der Windt, G. J. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.035 · Cited by 1,443
Palsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397
Sena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-249540 · Cited by 1,246
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
Battaglia, M., Stabilini, A., & Roncarolo, M.-G. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,134
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Zelenay, S., van der Veen, A. G., Böttcher, J. P., Snelgrove, K. J., Rogers, N., Acton, S. E., Chakravarty, P., Girotti, M. R., Marais, R., Quezada, S. A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.015 · Cited by 1,128
Macintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,127
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., & Ostrand-Rosenberg, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2587 · Cited by 949
Metabolic Reprogramming of Macrophages
Freemerman, A. J., Johnson, A. R., Sacks, G. N., Milner, J. J., Kirk, E. L., Troester, M. A., Macintyre, A. N., Goraksha-Hicks, P., Rathmell, J. C., & Makowski, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.522037 · Cited by 947
Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.-Y., Sack, M. N., Kastner, D. L., & Siegel, R. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102049 · Cited by 860
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 850
Carr, E. L., Kelman, A., Wu, G. S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A. M., & Frauwirth, K. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903586 · Cited by 830
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Peng, M., Yin, N., Chhangawala, S., Xu, K., Leslie, C. S., & Li, M. O. (2016) · Science · doi:10.1126/science.aaf6284 · Cited by 787
Haas, R., Smith, J., Rocher-Ros, V., Nadkarni, S., Montero-Melendez, T., D’Acquisto, F., Bland, E. J., Bombardieri, M., Pitzalis, C., Perretti, M., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002202 · Cited by 774
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729
Self-citationThe monocarboxylate transporter family—Structure and functional characterization
Halestrap, A. P. (2012) · IUBMB Life · doi:10.1002/iub.573 · Cited by 710
Rao, R. R., Li, Q., Odunsi, K., & Shrikant, P. A. (2010) · Immunity · doi:10.1016/j.immuni.2009.10.010 · Cited by 656 · cited 1×
“From another perspective, however, treatment with rapamycin reduces the proliferation of effector T cells and stabilizes/expands Tregs (135, 136), but at the same time can increase the presence of antitumor CD8 effector memory cells (137, 138).”
BackgroundThe TSC-mTOR pathway regulates macrophage polarization
Byles, V., Covarrubias, A. J., Ben-Sahra, I., Lamming, D. W., Sabatini, D. M., Manning, B. D., & Horng, T. (2013) · Nature Communications · doi:10.1038/ncomms3834 · Cited by 633
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Brandacher, G., Perathoner, A., Ladurner, R., Schneeberger, S., Obrist, P., Winkler, C., Werner, E. R., Werner-Felmayer, G., Weiss, H. G., G√∂bel, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1966 · Cited by 614
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., & Ochoa, A. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050715 · Cited by 609
Metabolic switching and fuel choice during T‐cell differentiation and memory development
van der Windt, G. J. W., & Pearce, E. L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01150.x · Cited by 563
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Eikawa, S., Nishida, M., Mizukami, S., Yamazaki, C., Nakayama, E., & Udono, H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417636112 · Cited by 557
Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression
Gerriets, V. A., Kishton, R. J., Johnson, M. O., Cohen, S., Siska, P. J., Nichols, A. G., Warmoes, M. O., de Cubas, A. A., MacIver, N. J., Locasale, J. W., et al. (2016) · Nature Immunology · doi:10.1038/ni.3577 · Cited by 539
Self-citationRole of Oxidants in NF-κB Activation and TNF-α Gene Transcription Induced by Hypoxia and Endotoxin
Chandel, N. S., Trzyna, W. C., McClintock, D. S., & Schumacker, P. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1013 · Cited by 537
Huang, S., Apasov, S., Koshiba, M., & Sitkovsky, M. (1997) · Blood · doi:10.1182/blood.v90.4.1600 · Cited by 531
Klysz, D., Tai, X., Robert, P. A., Craveiro, M., Cretenet, G., Oburoglu, L., Mongellaz, C., Floess, S., Fritz, V., Matias, M. I., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aab2610 · Cited by 522
Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch
Gubser, P. M., Bantug, G. R., Razik, L., Fischer, M., Dimeloe, S., Hoenger, G., Durovic, B., Jauch, A., & Hess, C. (2013) · Nature Immunology · doi:10.1038/ni.2687 · Cited by 493
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Donnelly, R. P., Loftus, R. M., Keating, S. E., Liou, K. T., Biron, C. A., Gardiner, C. M., & Finlay, D. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401558 · Cited by 485
Discrete Generation of Superoxide and Hydrogen Peroxide by T Cell Receptor Stimulation
Devadas, S., Zaritskaya, L., Rhee, S. G., Oberley, L., & Williams, M. S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010659 · Cited by 458
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Allard, B., Pommey, S., Smyth, M. J., & Stagg, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0545 · Cited by 458
Maschek, G., Savaraj, N., Priebe, W., Braunschweiger, P., Hamilton, K., Tidmarsh, G. F., De Young, L. R., & Lampidis, T. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3294 · Cited by 451
Glutamine metabolism in lymphocytes of the rat
Ardawi, M. S. M., & Newsholme, E. A. (1983) · Biochemical Journal · doi:10.1042/bj2120835 · Cited by 440
Fatty acid metabolism in the regulation of T cell function
Lochner, M., Berod, L., & Sparwasser, T. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.005 · Cited by 419
Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes
Dietl, K., Renner, K., Dettmer, K., Timischl, B., Eberhart, K., Dorn, C., Hellerbrand, C., Kastenberger, M., Kunz-Schughart, L. A., Oefner, P. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902584 · Cited by 401
Self-citationDe Rosa, V., Galgani, M., Porcellini, A., Colamatteo, A., Santopaolo, M., Zuchegna, C., Romano, A., De Simone, S., Procaccini, C., La Rocca, C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3269 · Cited by 398
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., Iafrate, M., Prayer-Galetti, T., Pagano, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042028 · Cited by 396
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Braun, D., Longman, R. S., & Albert, M. L. (2005) · Blood · doi:10.1182/blood-2005-03-0979 · Cited by 391
The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells
Newsholme, E. A., Crabtree, B., & Ardawi, M. S. M. (1985) · Bioscience Reports · doi:10.1007/bf01116556 · Cited by 364
Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy
Swamy, M., Pathak, S., Grzes, K. M., Damerow, S., Sinclair, L. V., van Aalten, D. M. F., & Cantrell, D. A. (2016) · Nature Immunology · doi:10.1038/ni.3439 · Cited by 350
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
Platten, M., von Knebel Doeberitz, N., Oezen, I., Wick, W., & Ochs, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00673 · Cited by 340
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation
Mendler, A. N., Hu, B., Prinz, P. U., Kreutz, M., Gottfried, E., & Noessner, E. (2012) · International Journal of Cancer · doi:10.1002/ijc.26410 · Cited by 319
Self-citationLöb, S., Königsrainer, A., Zieker, D., Brücher, B. L. D. M., Rammensee, H.-G., Opelz, G., & Terness, P. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0513-6 · Cited by 304
Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0425 · Cited by 300
Veltman, J. D., Lambers, M. E., van Nimwegen, M., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G., & Hegmans, J. P. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-464 · Cited by 291
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., & Inoue, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7175 · Cited by 285
l -Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
Fletcher, M., Ramirez, M. E., Sierra, R. A., Raber, P., Thevenot, P., Al-Khami, A. A., Sanchez-Pino, D., Hernandez, C., Wyczechowska, D. D., Ochoa, A. C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1491 · Cited by 281
Beier, U. H., Angelin, A., Akimova, T., Wang, L., Liu, Y., Xiao, H., Koike, M. A., Hancock, S. A., Bhatti, T. R., Han, R., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-268409 · Cited by 275
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Ryzhov, S., Novitskiy, S. V., Goldstein, A. E., Biktasova, A., Blackburn, M. R., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101225 · Cited by 261
Kamiński, M. M., Sauer, S. W., Klemke, C.-D., Süss, D., Okun, J. G., Krammer, P. H., & Gülow, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901662 · Cited by 255
Monocarboxylate transporter MCT1 is a target for immunosuppression
Murray, C. M., Hutchinson, R., Bantick, J. R., Belfield, G. P., Benjamin, A. D., Brazma, D., Bundick, R. V., Cook, I. D., Craggs, R. I., Edwards, S., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio744 · Cited by 248
Cheong, J.-H., Park, E. S., Liang, J., Dennison, J. B., Tsavachidou, D., Nguyen-Charles, C., Wa Cheng, K., Hall, H., Zhang, D., Lu, Y., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0497 · Cited by 245
Cancer metabolism: Key players in metabolic reprogramming
Soga, T. (2013) · Cancer Science · doi:10.1111/cas.12085 · Cited by 244
A broken Krebs cycle in macrophages
O’Neill, L. A. J. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.017 · Cited by 232
Brahimi-Horn, M. C., & Pouysségur, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.035022 · Cited by 226
Metabolism, migration and memory in cytotoxic T cells
Finlay, D., & Cantrell, D. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2888 · Cited by 225
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
Hulleman, E., Kazemier, K. M., Holleman, A., VanderWeele, D. J., Rudin, C. M., Broekhuis, M. J. C., Evans, W. E., Pieters, R., & Den Boer, M. L. (2009) · Blood · doi:10.1182/blood-2008-05-157842 · Cited by 213
Phan, A. T., Doedens, A. L., Palazon, A., Tyrakis, P. A., Cheung, K. P., Johnson, R. S., & Goldrath, A. W. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.017 · Cited by 208
Häusler, S. F. M., Montalbán del Barrio, I., Strohschein, J., Anoop Chandran, P., Engel, J. B., Hönig, A., Ossadnik, M., Horn, E., Fischer, B., Krockenberger, M., et al. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1040-4 · Cited by 193
Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 188
Eichner, R., Heider, M., Fernández-Sáiz, V., van Bebber, F., Garz, A.-K., Lemeer, S., Rudelius, M., Targosz, B.-S., Jacobs, L., Knorn, A.-M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4128 · Cited by 183
Maftouh, M., Avan, A., Sciarrillo, R., Granchi, C., Leon, L. G., Rani, R., Funel, N., Smid, K., Honeywell, R., Boggi, U., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.681 · Cited by 180
Role of glutamate on T-cell mediated immunity
Pacheco, R., Gallart, T., Lluis, C., & Franco, R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.01.003 · Cited by 178
Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
Stockwin, L. H., Yu, S. X., Borgel, S. D., Hancock, C. N., Wolfe, T. L., Phillips, L. R., Hollingshead, M. G., & Newton, D. L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25499 · Cited by 175
Denkert, C., Weichert, W., Winzer, K., Müller, B., Noske, A., Niesporek, S., Kristiansen, G., Guski, H., Dietel, M., & Hauptmann, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0070 · Cited by 175
Signaling defects in T lymphocytes of patients with malignancy
Whiteside, T. L. (1999) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050585 · Cited by 162
Singer, K., Kastenberger, M., Gottfried, E., Hammerschmied, C. G., Büttner, M., Aigner, M., Seliger, B., Walter, B., Schlösser, H., Hartmann, A., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25543 · Cited by 160
Self-citationMiraki‐Moud, F., Ghazaly, E. A., Ariza‐McNaughton, L., Hodby, K. A., Clear, A. J., Anjos‐Afonso, F., Liapis, K., Grantham, M., Sohrabi, F., Cavenagh, J. D., et al. (2015) · Blood · doi:10.1182/blood-2014-10-608133 · Cited by 158
Metabolic requirements for cancer cell proliferation
Keibler, M. A., Wasylenko, T. M., Kelleher, J. K., Iliopoulos, O., Heiden, M. G. V., & Stephanopoulos, G. N. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0156-6 · Cited by 158
Certain Metabolic and Pharmacologic Effects in Cancer Patients Given Infusions of 2-Deoxy-D-Glucose
Landau, B. R., László, J., Stengle, J. M., & Burk, D. (1958) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/21.3.485 · Cited by 152
Araki, K., Ellebedy, A. H., & Ahmed, R. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.08.006 · Cited by 146
Characterization of Methylthioadenosin Phosphorylase (MTAP) Expression in Malignant Melanoma
Behrmann, I., Wallner, S., Komyod, W., Heinrich, P. C., Schuierer, M. M., Buettner, R., & Bosserhoff, A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63695-4 · Cited by 145
Mazurek, S., & EIGENBRODT, E. (2003) · PubMed · Cited by 140
Obre, E., & Rossignol, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.12.008 · Cited by 137
New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
Gottfried, E., Lang, S. A., Renner, K., Bosserhoff, A., Gronwald, W., Rehli, M., Einhell, S., Gedig, I., Singer, K., Seilbeck, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066987 · Cited by 133
Self-citationRegulation of Cancer Metabolism by Oncogenes and Tumor Suppressors
Iurlaro, R., León‐Annicchiarico, C. L., & Muñoz‐Pinedo, C. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00003-0 · Cited by 129
Influence of glutamine on the phenotype and function of human monocytes
Spittler, A., Winkler, S., Götzinger, P., Oehler, R., Willheim, M., Tempfer, C. M., Weigel, G. J., Függer, R., Boltz‐Nitulescu, G., & Roth, E. (1995) · Blood · doi:10.1182/blood.v86.4.1564.bloodjournal8641564 · Cited by 117
Chirasani, S. R., Leukel, P., Gottfried, E., Hochrein, J., Stadler, K., Neumann, B. H., Oefner, P. J., Gronwald, W., Bogdahn, U., Hau, P., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27712 · Cited by 114
Self-citationWarburg, O. H., Gawehn, K., & Geissler, A.-W. (1958) · PubMed · Cited by 111
c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells
Chou, C., Pinto, A. K., Curtis, J. D., Persaud, S. P., Cella, M., Lin, C., Edelson, B. T., Allen, P. M., Colonna, M., Pearce, E. L., et al. (2014) · Nature Immunology · doi:10.1038/ni.2943 · Cited by 109
Choi, B.-S., Martinez-Falero, I. C., Corset, C., Munder, M., Modolell, M., Müller, I., & Kropf, P. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0508310 · Cited by 107
Zheng, X., Koropatnick, J. D., Chen, D., Velenosi, T. J., Ling, H., Zhang, X., Jiang, N., Navarro, B., Ichim, T. E., Urquhart, B. L., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27710 · Cited by 105
Stoffwechsel der weißen Blutzellen
Warburg, O. H., Gawehn, K., & Geissler, A.-W. (1958) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1958-0806 · Cited by 102
Serine-threonine kinases in TCR signaling
Navarro, M. N., & Cantrell, D. A. (2014) · Nature Immunology · doi:10.1038/ni.2941 · Cited by 99
Renner, K., Geiselhöringer, A.-L., Fante, M. A., Bruß, C., Färber, S., Schoenhammer, G., Peter, K., Singer, K., Andreesen, R., Hoffmann, P., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545473 · Cited by 98
Self-citationA Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA
Yen, M., Lin, C., Chen, Y., Huang, S.-S., Yang, H., Chang, C., Lei, H.-Y., & Lai, M.-D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1988 · Cited by 88
TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis
Salerno, F., Guislain, A., Cansever, D., & Wolkers, M. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501997 · Cited by 87
Moretti, S., Menicali, E., Voce, P., Morelli, S., Cantarelli, S., Sponziello, M., Colella, R., Fallarino, F., Orabona, C., Alunno, A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3351 · Cited by 83
Radoja, S., & Frey, A. B. (2000) · Molecular Medicine · doi:10.1007/bf03401788 · Cited by 78
Prognostic Impact of Cyclooxygenase-2 in Breast Cancer
Denkert, C., Winzer, K., & Hauptmann, S. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.006 · Cited by 78
Van de Velde, L.-A., Subramanian, C., Smith, A. M., Barron, L., Qualls, J. E., Neale, G., Alfonso-Pecchio, A., Jackowski, S., Rock, C. O., Wynn, T. A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.766238 · Cited by 75
Post-transplantation malignancies: here today, gone tomorrow?
Geissler, E. K. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.186 · Cited by 75
Self-citationSuppressive effects of tumor cell-derived 5′-deoxy-5′-methylthioadenosine on human T cells
Henrich, F. C., Singer, K., Poller, K., Bernhardt, L., Strobl, C. D., Limm, K., Ritter, A. P., Gottfried, E., Völkl, S., Jacobs, B., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1184802 · Cited by 69
Self-citationBusse, A., Asemissen, A. M., Nonnenmacher, A., Braun, F., Ochsenreither, S., Stather, D., Fusi, A., Schmittel, A. H., Miller, K., Thiel, E., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.021 · Cited by 65
Basu, S., Hubbard, B., & Shevach, E. M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ab0514-273rr · Cited by 64
Stevens, A. P., Spangler, B., Wallner, S., Kreutz, M. P., Dettmer, K., Oefner, P. J., & Bosserhoff, A. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21984 · Cited by 61
Self-citationChristie, D. A., Mitsopoulos, P., Blagih, J., Dunn, S. D., St‐Pierre, J., Jones, R. G., Hatch, G. M., & Madrenas, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103829 · Cited by 57
Glutamine Modulates Macrophage Lipotoxicity
He, L. N., Weber, K., & Schilling, J. D. (2016) · Nutrients · doi:10.3390/nu8040215 · Cited by 56
Phosphate‐activated glutaminase expression during tumor development
Aledo, J. C., Segura, J. A., Medina, M. Á., Alonso, F. J., de Castro, I. N., & Márquez, J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80236-x · Cited by 54
Effect of diclofenac on SLC16A3/MCT4 by the Caco-2 cell line
Sasaki, S., Futagi, Y., Ideno, M., Kobayashi, M., Narumi, K., Furugen, A., & Iseki, K. (2016) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2016.03.004 · Cited by 50
Dziurla, R., Gaber, T., Fangradt, M., Hahne, M., Tripmacher, R., Kolar, P., Spies, C. M., Burmester, G. R., & Buttgereit, F. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.02.008 · Cited by 49
Eleftheriadis, T., Pissas, G., Karioti, A., Antoniadi, G., Antoniadis, N., Liakopoulos, V., & Stefanidis, I. (2013) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2013-0001 · Cited by 49
Gandhi, A. K., Shi, T., Li, M., Jungnelius, U., Romano, A., Tabernero, J. M., Siena, S., Schafer, P. H., & Chopra, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080437 · Cited by 34
Thakur, A. B., Schalk, D. L., Tomaszewski, E. N., Kondadasula, S. V., Yano, H., Sarkar, F. H., & Lum, L. G. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-35 · Cited by 34
Inhibition of mTORC1 signaling sensitizes hepatocellular carcinoma cells to glycolytic stress.
Zhao, X., Jiang, P., Deng, X., Li, Z., Tian, F., Guo, F., Li, X., & Wang, S. (2016) · PubMed · Cited by 20
Rovira, J., Sabet-Baktach, M., Eggenhofer, E., Lantow, M., Koehl, G. E., Schlitt, H. J., Campistol, J. M., Geissler, E. K., & Kroemer, A. (2012) · Transplantation · doi:10.1097/tp.0b013e318276d358 · Cited by 19
Self-citationThe Metabolic Achilles Heel: Tumor Cell Metabolism as Therapeutic Target
Gottfried, E., Peter, K., & Kreutz, M. P. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_7 · Cited by 2
Self-citation
Cited by
ESPEN expert group recommendations for action against cancer-related malnutrition
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E. P., Erickson, N., Laviano, A., Lisanti, M. P., Lobo, D. N., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.017 · Cited by 1,305
Martinez, M., & Moon, E. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00128 · Cited by 851
Metabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Cascone, T., McKenzie, J. A., Mbofung, R. M., Punt, S., Wang, Z., Xu, C., Williams, L. J., Wang, Z., Bristow, C. A., Carugo, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.024 · Cited by 611
Glucose transporters in cancer – from tumor cells to the tumor microenvironment
Ancey, P., Contat, C., & Meylan, E. (2018) · The FEBS Journal · doi:10.1111/febs.14577 · Cited by 514
Metadata
- Authors
- Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-03-08
- Volume
- 8
- Pages
- 248-248
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2594575075
- Cited by
- 374
- References
- 142
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.